These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6430313)

  • 1. Pharmacokinetics of valproic acid in the elderly.
    Perucca E; Grimaldi R; Gatti G; Pirracchio S; Crema F; Frigo GM
    Br J Clin Pharmacol; 1984 Jun; 17(6):665-9. PubMed ID: 6430313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of valproic acid in young and elderly subjects.
    Bryson SM; Verma N; Scott PJ; Rubin PC
    Br J Clin Pharmacol; 1983 Jul; 16(1):104-5. PubMed ID: 6411107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of old age and enzyme inducing comedication on the pharmacokinetics of valproic acid at steady-state: A case-matched evaluation based on therapeutic drug monitoring data.
    Fattore C; Messina S; Battino D; Croci D; Mamoli D; Perucca E
    Epilepsy Res; 2006 Aug; 70(2-3):153-60. PubMed ID: 16730950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of valproic acid in volunteers after a single dose study.
    Bialer M; Hussein Z; Raz I; Abramsky O; Herishanu Y; Pachys F
    Biopharm Drug Dispos; 1985; 6(1):33-42. PubMed ID: 3921078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug treatment of epilepsy in elderly people: focus on valproic Acid.
    Stephen LJ
    Drugs Aging; 2003; 20(2):141-52. PubMed ID: 12534314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disposition of valproic acid in man.
    Gugler R; Schell A; Eichelbaum M; Fröscher W; Schulz HU
    Eur J Clin Pharmacol; 1977 Oct; 12(2):125-32. PubMed ID: 336377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of total and free valproic acid during monotherapy in infants.
    Herngren L; Lundberg B; Nergårdh A
    J Neurol; 1991 Sep; 238(6):315-9. PubMed ID: 1940980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproic acid clearance: unbound fraction and diurnal variation in young and elderly adults.
    Bauer LA; Davis R; Wilensky A; Raisys V; Levy RH
    Clin Pharmacol Ther; 1985 Jun; 37(6):697-700. PubMed ID: 3924464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproic acid-ethosuximide interaction: a pharmacokinetic study.
    Pisani F; Narbone MC; Trunfio C; Fazio A; La Rosa G; Oteri G; Di Perri R
    Epilepsia; 1984 Apr; 25(2):229-33. PubMed ID: 6423377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of peritoneal dialysis on the single dose and steady state pharmacokinetics of valproic acid in a uremic epileptic child.
    Orr JM; Farrell K; Abbott FS; Ferguson S; Godolphin WJ
    Eur J Clin Pharmacol; 1983; 24(3):387-90. PubMed ID: 6407847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo plasma protein binding interaction between valproic acid and naproxen.
    Grimaldi R; Lecchini S; Crema F; Perucca E
    Eur J Drug Metab Pharmacokinet; 1984; 9(4):359-63. PubMed ID: 6442704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition of valproic acid in maternal, fetal, and newborn sheep. I: placental transfer, plasma protein binding, and clearance.
    Kumar S; Wong H; Yeung SA; Riggs KW; Abbott FS; Rurak DW
    Drug Metab Dispos; 2000 Jul; 28(7):845-56. PubMed ID: 10859159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability of calcium valproate in normal men compared with the free acid and sodium salt.
    Glazko AJ; Chang T; Daftsios AC; Eiseman I; Smith TC; Buchanan RA
    Ther Drug Monit; 1983; 5(4):409-17. PubMed ID: 6419419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-related pharmacokinetics and pharmacodynamics of valproate in the elderly.
    Felix S; Sproule BA; Hardy BG; Naranjo CA
    J Clin Psychopharmacol; 2003 Oct; 23(5):471-8. PubMed ID: 14520124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meal-dependent absorption of enteric-coated sodium valproate.
    Levy RH; Cenraud B; Loiseau P; Akbaraly R; Brachet-Liermain A; Guyot M; Gomeni R; Morselli PL
    Epilepsia; 1980 Jun; 21(3):273-80. PubMed ID: 6769666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of carbamazepine on valproic acid disposition in adult volunteers.
    Panesar SK; Orr JM; Farrell K; Burton RW; Kassahun K; Abbott FS
    Br J Clin Pharmacol; 1989 Mar; 27(3):323-8. PubMed ID: 2497766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valproic acid dosage and plasma protein binding and clearance.
    Bowdle AT; Patel IH; Levy RH; Wilensky AJ
    Clin Pharmacol Ther; 1980 Oct; 28(4):486-92. PubMed ID: 6773716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition of sodium valproate in epileptic patients.
    Perucca E; Gatti G; Frigo GM; Crema A; Calzetti S; Visintini D
    Br J Clin Pharmacol; 1978 Jun; 5(6):495-9. PubMed ID: 350251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of valproic acid obtained after administration of three oral formulations to humans.
    Bialer M; Hussein Z; Dubrovsky J; Raz I; Abramsky O
    Isr J Med Sci; 1984 Jan; 20(1):46-9. PubMed ID: 6421770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of amoxicillin/clavulanic acid on the pharmacokinetics of valproic acid.
    Lee SY; Huh W; Jung JA; Yoo HM; Ko JW; Kim JR
    Drug Des Devel Ther; 2015; 9():4559-63. PubMed ID: 26309401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.